Corynebacterium CDC group JK (Corynebacterium jeikeium) sepsis in haematological patients: a report of three cases and a systematic literature review

Scand J Infect Dis. 1995;27(6):581-4. doi: 10.3109/00365549509047071.

Abstract

We describe 3 patients with Corynebacterium jeikeium sepsis in neutropenic phase during treatment for acute myeloid leukaemia. Fever was the first symptom. All had a central venous catheter which was removed. Two patients developed subcutaneous nodules containing pus when the neutrophil count recovered; 1 had intracutaneous and pulmonary lesions. They were treated with vancomycin and recovered when the neutrophil count started to rise. A review of 80 neutropenic patients with C. jeikeium sepsis reported in the literature, together with our 3 cases indicates that risk factors for infection are the presence of a central venous catheter, being an adult male or postmenopausal female, profound and prolonged neutropenia and exposure to multiple antibiotics. Skin lesions are reported in 48% and pulmonary lesions in 36% of the patients. The overall mortality is 34% but in patients with recovery of the bone marrow only 5%. Therefore haematopoietic growth factors should be considered in neutropenic patients with C. jeikeium infection.

Publication types

  • Case Reports
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / etiology*
  • Bacteremia / physiopathology
  • Corynebacterium / classification*
  • Corynebacterium / isolation & purification
  • Corynebacterium Infections / drug therapy
  • Corynebacterium Infections / etiology*
  • Corynebacterium Infections / physiopathology
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Humans
  • Immunocompromised Host*
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / immunology
  • Male
  • Middle Aged
  • Neutropenia / complications
  • Prognosis

Substances

  • Anti-Bacterial Agents